These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34046709)

  • 21. Vascular applications of ferumoxytol-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Bowman AW; Gooch CR; Alexander LF; Desai MA; Bolan CW
    Abdom Radiol (NY); 2021 May; 46(5):2203-2218. PubMed ID: 33090256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
    Luhar A; Khan S; Finn JP; Ghahremani S; Griggs R; Zaritsky J; Salusky I; Hall TR
    Pediatr Radiol; 2016 Aug; 46(9):1332-40. PubMed ID: 27059620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort.
    Nayak AB; Luhar A; Hanudel M; Gales B; Hall TR; Finn JP; Salusky IB; Zaritsky J
    Pediatr Nephrol; 2015 Mar; 30(3):515-21. PubMed ID: 25212105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular MRI with ferumoxytol.
    Finn JP; Nguyen KL; Han F; Zhou Z; Salusky I; Ayad I; Hu P
    Clin Radiol; 2016 Aug; 71(8):796-806. PubMed ID: 27221526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.
    Nguyen KL; Yoshida T; Kathuria-Prakash N; Zaki IH; Varallyay CG; Semple SI; Saouaf R; Rigsby CK; Stoumpos S; Whitehead KK; Griffin LM; Saloner D; Hope MD; Prince MR; Fogel MA; Schiebler ML; Roditi GH; Radjenovic A; Newby DE; Neuwelt EA; Bashir MR; Hu P; Finn JP
    Radiology; 2019 Dec; 293(3):554-564. PubMed ID: 31638489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ferumoxytol-Enhanced MRI Is Not Inferior to Gadolinium-Enhanced MRI in Detecting Intracranial Metastatic Disease and Metastasis Size.
    Hamilton BE; Barajas R; Nesbit GM; Fu R; Ambady P; Taylor M; Neuwelt EA
    AJR Am J Roentgenol; 2020 Dec; 215(6):1436-1442. PubMed ID: 33052739
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety of Off-Label Use of Ferumoxtyol as a Contrast Agent for MRI: A Systematic Review and Meta-Analysis of Adverse Events.
    Ahmad F; Treanor L; McGrath TA; Walker D; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2021 Mar; 53(3):840-858. PubMed ID: 33098154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferumoxytol in clinical practice: implications for MRI.
    McCullough BJ; Kolokythas O; Maki JH; Green DE
    J Magn Reson Imaging; 2013 Jun; 37(6):1476-9. PubMed ID: 23097302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
    Neuwelt EA; Hamilton BE; Varallyay CG; Rooney WR; Edelman RD; Jacobs PM; Watnick SG
    Kidney Int; 2009 Mar; 75(5):465-74. PubMed ID: 18843256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of ferumoxytol for high-resolution vascular imaging and troubleshooting for abdominal allografts.
    Shah A; Neitzel E; Panda A; Fananapazir G
    Abdom Radiol (NY); 2024 Aug; 49(8):2858-2872. PubMed ID: 38561553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific.
    McConnell HL; Schwartz DL; Richardson BE; Woltjer RL; Muldoon LL; Neuwelt EA
    Nanomedicine; 2016 Aug; 12(6):1535-42. PubMed ID: 27071335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle.
    Castaneda RT; Khurana A; Khan R; Daldrup-Link HE
    J Vis Exp; 2011 Nov; (57):e3482. PubMed ID: 22083287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent.
    Varallyay CG; Toth GB; Fu R; Netto JP; Firkins J; Ambady P; Neuwelt EA
    AJNR Am J Neuroradiol; 2017 Jul; 38(7):1297-1302. PubMed ID: 28495944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease.
    Kowalczyk M; Banach M; Rysz J
    J Nephrol; 2011; 24(6):717-22. PubMed ID: 21956770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
    Varallyay P; Nesbit G; Muldoon LL; Nixon RR; Delashaw J; Cohen JI; Petrillo A; Rink D; Neuwelt EA
    AJNR Am J Neuroradiol; 2002 Apr; 23(4):510-9. PubMed ID: 11950637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging of stem cell-macrophage interactions with ferumoxytol and ferumoxytol-derived nanoparticles.
    Nejadnik H; Tseng J; Daldrup-Link H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1552. PubMed ID: 30734542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging Tumor Necrosis with Ferumoxytol.
    Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
    PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular Imaging With Ferumoxytol as a Contrast Agent.
    Hope MD; Hope TA; Zhu C; Faraji F; Haraldsson H; Ordovas KG; Saloner D
    AJR Am J Roentgenol; 2015 Sep; 205(3):W366-73. PubMed ID: 26102308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach.
    Muehe AM; Theruvath AJ; Lai L; Aghighi M; Quon A; Holdsworth SJ; Wang J; Luna-Fineman S; Marina N; Advani R; Rosenberg J; Daldrup-Link HE
    Mol Imaging Biol; 2018 Apr; 20(2):324-335. PubMed ID: 28721605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle.
    Huang Y; Hsu JC; Koo H; Cormode DP
    Theranostics; 2022; 12(2):796-816. PubMed ID: 34976214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.